S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

Ceradyne (CRDN) Gets Expected Follow-on Order

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

By William Trent, CFA of Stock Market Beat

Ceradyne (CRDN) opened sharply higher this morning when they announced some good news. Ceradyne Gets $133 Million Army Contract – 12/22/2006 4:31:00 AM – Manufacturing.Net – CA6402229

Ceradyne said Firday it received a $133 million delivery order for Enhanced Side Ballistic Inserts (ESBI) from the U.S. Army, Aberdeen Proving Ground, Maryland.

The thing is, the order was part of an already announced contract. For sales to the military companies generally get an umbrella contract for a large quantity over multiple years. However, each year’s portion is subject to Congressional approval. So while it would have been bad news if the company did not receive the follow-on, receiving it was more or less expected.

As trading continues, it appears the market is coming to this conclusion, as half the initial gains have been reversed.

The author may hold a position in the securities discussed. The author’s current holdings are as follows: Long: Union Pacific (UNP) put options; Air Products (APD) put options; Nasdaq 100 (QQQQ) put options; FedEx (FDX) put options; Intuit (INTU) put options; Bookham (BKHM; Ballard Power (BLDP); Syntax Brillian (BRLC); CMGI (CMGI); Genentech (DNA); Ion Media Networks (ION); Three Five Systems (TFS); IShares Japan (EWJ); StreetTracks Gold (GLD); Starbucks (SBUX); U.S. Oil Fund (USO); Plantronics (PLT) call options; Short: Landstar (LSTR) put options; Ceradyne (CRDN) put options; Dell (DELL) put options; Plantronics (PLT) put options

http://stockmarketbeat.com/blog1/

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Douglas A. McIntyre |

CRDN: Ceradyne Makes More Sales We Already Knew About

By William Trent, CFA of Stock Market Beat The way the defense spending process works, companies selling to the military…
Douglas A. McIntyre |

Ceradyne’s (CRDN) Good News is No News

By William Trent, CFA of Stock Market Beat We have done about as well this year betting that Ceradyne (CRDN)…
Douglas A. McIntyre |

Xilinx Revises December Quarter FY07 Guidance

By William Trent, CFA of Stock Market Beat Hot on the heels of the National Semiconductor (NSM) disappointment,  Xilinx (XLNX)…
Douglas A. McIntyre |

SEMI Cycle Downturn Now Clear as Day

By William Trent, CFA of Stock Market Beat According to Semiconductor Equipment and Materials International (SEMI), North American-based manufacturers of…
Douglas A. McIntyre |

The Hunter (Phelps Dodge) Becomes the Hunted

As Bill Cara predicted several months ago, Phelps Dodge’s (PD) bid for Inco and Falconbridge has been thwarted, and has…
Douglas A. McIntyre |

Hewitt: Another Miss, Still Not Cheap Enough

By William Trent, CFA of Stock Market BeatWe have looked at benefits outsourcing firm Hewitt Associates (HEW) several times, and…
Douglas A. McIntyre |

Sprint the Latest Wireless Signal to Get Crossed

By William Trent, CFA of Stock Market Beat Last month, astute observers (defined as those with a pulse) could notice…
Douglas A. McIntyre |

Leading Apps Vendors Compete for Telecom Customers

By William Trent, CFA of Stock Market Beat IBM to buy Vallent for telecom expertise | InfoWorld | News |…
Douglas A. McIntyre |

Jobs Growth Still Looks Like its Weakening

By William Trent, CFA of Stock Market Beat The jobs report is out, and receiving a fairly warm welcome. Economy…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618